Business Context and Reporting Period
This Form 8-K Current Report was filed by Nephros, Inc. on November 22, 2013, with the latest event reported on November 29, 2013. The filing addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Director Resignation: James S. Scibetta resigned as a director, effective December 31, 2013.
- Director Appointment: Daron Evans was appointed to the Board on November 29, 2013.
- Committee Assignment: Mr. Evans will serve on the Audit Committee.
- Term: Mr. Evans' initial term expires at the 2014 annual meeting of stockholders.
- Compensation: Mr. Evans will receive standard compensation and indemnification approved for non-employee directors.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document includes a press release dated November 29, 2013, as an exhibit but does not summarize its contents within the main text.
Key Facts for Investor Verification
- Confirm the effective date of James S. Scibetta's resignation (December 31, 2013).
- Verify Daron Evans' qualifications and background for the Audit Committee role.
- Review the attached Press Release (Exhibit 99.1) for additional context on the board changes.
- Check subsequent filings for the outcome of the 2014 annual meeting regarding Mr. Evans' re-election.